Developmental Bisphenol A Exposure Modulates Immune-Related Diseases

Area of Science:

• Environmental health
• Immunology
• Endocrinology

Background:

• Bisphenol A (BPA) is a common environmental chemical found in plastics and resins.
• BPA exposure occurs widely in humans, including during development via placental transfer and breast milk.
• BPA's endocrine-disrupting properties raise concerns about its impact on immune system development and related diseases.

Purpose of the Study:

• To review the mechanisms by which developmental Bisphenol A (BPA) exposure modulates the immune system.
• To examine the association between developmental BPA exposure and immune-related disease development.
• To highlight the need for research on BPA analogs, such as bisphenol S (BPS), and their immunomodulatory effects.

Main Methods:

• Review of existing scientific literature on Bisphenol A (BPA) and its effects on the immune system.
• Analysis of proposed mechanisms of immunomodulation, including receptor interactions, epigenetic changes, and gut microbiome alterations.
• Examination of studies linking developmental BPA exposure to immune cell changes and disease outcomes.

Main Results:

• Developmental BPA exposure alters innate and adaptive immune cell populations and function.
• Decreased T regulatory (Treg) cells and altered cytokine/chemokine profiles are observed following BPA exposure.
• BPA exposure is linked to increased risk for type 2 diabetes mellitus, allergies, asthma, and mammary cancer; potential exacerbation of multiple sclerosis and type 1 diabetes.

Conclusions:

• Developmental exposure to Bisphenol A (BPA) significantly modulates immune responses and contributes to immune-related diseases.
• Further research is crucial to understand the long-term immune effects of BPA and its analogs, like bisphenol S (BPS).
• Public health strategies may need to consider the impact of widespread BPA exposure on immune health and disease prevention.